ACADIA PHARMACEUTICALS INC — Director's Dealing 2021

Jun 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2021-06-22

Reporting Person: GAROFALO ELIZABETH A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-22	Director Stock Options (Right to Buy)	$24.88	A	11637	Acquired	2031-06-21	Common Stock (11637)	Direct
2021-06-22	Restricted Stock Units	$	A	6391	Acquired		Common Stock (6391)	Direct

Footnotes

F1: The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.

F2: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F3: The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.